Entrada Therapeutics Inc
(TRDA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -104,586 | -60,452 | -17,349 | 65,626 | 64,495 |
| Depreciation Amortization | 172 | -319 | -392 | -6,245 | -4,730 |
| Accounts payable and accrued liabilities | -922 | -2,231 | -1,910 | 991 | -1,855 |
| Other Working Capital | -16,144 | -22,799 | -28,550 | -129,223 | -90,649 |
| Other Operating Activity | 25,171 | 17,805 | 9,694 | 27,294 | 22,787 |
| Operating Cash Flow | $-96,309 | $-67,996 | $-38,507 | $-41,557 | $-9,952 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 88,937 | 39,999 | 5,927 | -24,640 | -78,640 |
| PPE Investments | -1,248 | -1,419 | -1,144 | -3,158 | -2,523 |
| Investing Cash Flow | $87,689 | $38,580 | $4,783 | $-27,798 | $-81,163 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 695 | 687 | 350 | 102,964 | 101,562 |
| Financing Cash Flow | $695 | $687 | $350 | $102,964 | $101,562 |
| Beginning Cash Position | 105,161 | 105,161 | 105,161 | 71,552 | 71,552 |
| End Cash Position | 97,236 | 76,432 | 71,787 | 105,161 | 81,999 |
| Net Cash Flow | $-7,925 | $-28,729 | $-33,374 | $33,609 | $10,447 |
| Free Cash Flow | |||||
| Operating Cash Flow | -96,309 | -67,996 | -38,507 | -41,557 | -9,952 |
| Capital Expenditure | -1,248 | -1,419 | -1,144 | -3,158 | -2,523 |
| Free Cash Flow | -97,557 | -69,415 | -39,651 | -44,715 | -12,475 |